News

Kadant Solutions Launches Yankee Doctor Maintenance Kits

AUBURN, Mass., January 26, 2022 – Kadant Solutions, a division of Kadant Inc. (NYSE: KAI), launched two new Yankee doctor maintenance kits for the tissue making industry. In keeping with the quality and integrity of the Kadant Solutions Genuine Parts program, each kit includes the necessary items needed to maintain a Yankee doctoring system efficiently and effectively.

The kits are designed for the Kadant Solutions Conformatic™ creping blade holder family of products and provide the custom tools needed for Yankee doctor maintenance, including dial indicator, set up block assembly, sockets, and an AngleSet™ gauge with Bluetooth capability to connect to the Kadant AngleSet gauge mobile app. All components come in a durable hard case for easy storage.

“Using a Yankee doctor maintenance kit will help customers ensure their creping doctors are running effectively for optimum production in between service visits from their Kadant Solutions field service technician,” according to Scott Borges, product line manager for doctoring at Kadant Solutions.

About Kadant Solutions

Kadant Solutions, based in Auburn, Massachusetts, is a leading supplier of doctor blades, doctor blade holders, and doctoring systems for papermaking and other industrial processes. The company’s cleaning and conditioning products are applied to the cleaning of forming and press fabrics and the filtration of process water as well as engineered wet-end products for papermaking.

About Kadant

Kadant Inc. is a global supplier of high-value, critical components and engineered systems used in process industries worldwide. The Company’s products, technologies, and services play an integral role in enhancing process efficiency, optimizing energy utilization, and maximizing productivity in resource-intensive industries. Kadant is based in Westford, Massachusetts, with approximately 2,900 employees in 20 countries worldwide.

Safe Harbor Statement

The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties, including forward-looking statements about our products, technologies, and markets. These forward-looking statements represent our expectations as of the date of this press release. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause our actual results to differ materially from these forward-looking statements as a result of various important factors, including those set forth under the heading "Risk Factors" in Kadant’s annual report on Form 10-K for the fiscal year ended January 2, 2021 and subsequent filings with the Securities and Exchange Commission.

© Kadant Inc.